Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pitchaya Jaruvijitrattana"'
Publikováno v:
Case Reports in Dermatology, Vol 11, Iss 2, Pp 226-232 (2019)
Cytarabine is an antimetabolite commonly used to treat hematological malignancies, especially acute myeloid leukemia (AML), acute lymphoblastic leukemia, and non-Hodgkin’s lymphoma. Cytarabine-induced cutaneous adverse effects are common, usually m
Externí odkaz:
https://doaj.org/article/2b55a2877c3b42eb8835e4e3a15a6f40
Autor:
Dichitchai Mettarikanon, Weeratian Tawanwongsri, Pitchaya Jaruvijitrattana, Sasipaka Sindhusen, Surinnart Charoenchitt, Patsaraporn Manunyanon
Publikováno v:
Contemporary Educational Technology; Oct2023, Vol. 15 Issue 4, p1-10, 10p
Publikováno v:
Case Reports in Dermatology
Case Reports in Dermatology, Vol 11, Iss 2, Pp 226-232 (2019)
Case Reports in Dermatology, Vol 11, Iss 2, Pp 226-232 (2019)
Cytarabine is an antimetabolite commonly used to treat hematological malignancies, especially acute myeloid leukemia (AML), acute lymphoblastic leukemia, and non-Hodgkin’s lymphoma. Cytarabine-induced cutaneous adverse effects are common, usually m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37b679b7133f9ddecba7c245bbcd700f
https://doi.org/10.1159/000501876
https://doi.org/10.1159/000501876
Publikováno v:
Health & Medicine Week; 10/20/2023, p7240-7240, 1p
Autor:
Jaruvijitrattana, Pitchaya1 (AUTHOR), Chanprapaph, Kumutnart1 (AUTHOR) kumutnartp@hotmail.com
Publikováno v:
Case Reports in Dermatology. 2019, Vol. 11 Issue 2, p226-232. 7p.